 | • レポートコード：MRC23Q36319 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のリアルタイムPCR装置/試薬市場について調査・分析し、世界のリアルタイムPCR装置/試薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（試薬、器具）、用途別セグメント分析（感染症、産前/産後ケア、がん検診/治療、臓器移植、個体識別、農業、税関検疫、食品安全、法医学、研究開発）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Roche、DaAn Gene、Sansure Biotech、QIAGEN、Bio-Rad、Biosynex、Cepheid、Hangzhou Bloer Technology、Liferiver Bio-Tech、Xi'an Tianlong Science and Technology、Bioperfectus Technologies、BGI Group、Agilent Technologies、Hybribio、Shanghai Biogerm Medical、Shanghai Hongshi Medical Technology、Suzhou Molarray、Merck、Analytik Jena、Takara、Meridian Life Science、Promega Corporationなどが含まれています。 世界のリアルタイムPCR装置/試薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、リアルタイムPCR装置/試薬市場規模を推定する際に考慮しました。本レポートは、リアルタイムPCR装置/試薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、リアルタイムPCR装置/試薬に関するビジネス上の意思決定に役立てることを目的としています。 ・リアルタイムPCR装置/試薬市場の概要 - リアルタイムPCR装置/試薬のタイプ別セグメント - 世界のリアルタイムPCR装置/試薬市場規模：タイプ別分析（試薬、器具） - リアルタイムPCR装置/試薬の用途別セグメント - 世界のリアルタイムPCR装置/試薬市場規模：用途別分析（感染症、産前/産後ケア、がん検診/治療、臓器移植、個体識別、農業、税関検疫、食品安全、法医学、研究開発） - 世界のリアルタイムPCR装置/試薬市場規模予測（2018年-2029年） ・リアルタイムPCR装置/試薬市場の成長トレンド - リアルタイムPCR装置/試薬の地域別市場規模（2018年-2029年） - リアルタイムPCR装置/試薬市場ダイナミクス - リアルタイムPCR装置/試薬の業界動向 - リアルタイムPCR装置/試薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：試薬、器具 - 世界のリアルタイムPCR装置/試薬のタイプ別市場規模（2018年-2023年） - 世界のリアルタイムPCR装置/試薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：感染症、産前/産後ケア、がん検診/治療、臓器移植、個体識別、農業、税関検疫、食品安全、法医学、研究開発 - 世界のリアルタイムPCR装置/試薬の用途別市場規模（2018年-2023年） - 世界のリアルタイムPCR装置/試薬の用途別市場規模（2024年-2029年） ・リアルタイムPCR装置/試薬の地域別市場規模 - 北米のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - アメリカのリアルタイムPCR装置/試薬市場規模（2018年-2029年） - ヨーロッパのリアルタイムPCR装置/試薬市場規模（2018年-2029年） - アジア太平洋のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - 中国のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - 日本のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - 韓国のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - インドのリアルタイムPCR装置/試薬市場規模（2018年-2029年） - オーストラリアのリアルタイムPCR装置/試薬市場規模（2018年-2029年） - 中南米のリアルタイムPCR装置/試薬市場規模（2018年-2029年） - 中東・アフリカのリアルタイムPCR装置/試薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Roche、DaAn Gene、Sansure Biotech、QIAGEN、Bio-Rad、Biosynex、Cepheid、Hangzhou Bloer Technology、Liferiver Bio-Tech、Xi'an Tianlong Science and Technology、Bioperfectus Technologies、BGI Group、Agilent Technologies、Hybribio、Shanghai Biogerm Medical、Shanghai Hongshi Medical Technology、Suzhou Molarray、Merck、Analytik Jena、Takara、Meridian Life Science、Promega Corporation ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Real-time PCR Instrumentsand Reagents market was valued at US$ 6999 million in 2022 and is anticipated to reach US$ 10800 million by 2029, witnessing a CAGR of 7.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main manufacturers of Real-time PCR Instruments and Reagents are Thermo Fisher Scientific, Roche and DaAn Gene, etc. The top five manufacturers account for about 30% of the share. China is the largest market with around 45% share, followed by North America and Europe with over 20% and 15% share. Reagent is the largest segment with a roughly 70% share. Infectious Disease are the largest application, accounting for about 80% of the share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Real-time PCR Instrumentsand Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-time PCR Instrumentsand Reagents.
The Real-time PCR Instrumentsand Reagents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Real-time PCR Instrumentsand Reagents market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Real-time PCR Instrumentsand Reagents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Roche
DaAn Gene
Sansure Biotech
QIAGEN
Bio-Rad
Biosynex
Cepheid
Hangzhou Bloer Technology
Liferiver Bio-Tech
Xi’an Tianlong Science and Technology
Bioperfectus Technologies
BGI Group
Agilent Technologies
Hybribio
Shanghai Biogerm Medical
Shanghai Hongshi Medical Technology
Suzhou Molarray
Merck
Analytik Jena
Takara
Meridian Life Science
Promega Corporation
Segment by Type
Reagent
Instrument
Segment by Application
Infectious Disease
Prenatal and Postnatal Care
Cancer Screening and Treatment
Organ Transplant
Individual Identification
Agriculture
Customs Quarantine
Food Safety
Forensic
Research and Development
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Real-time PCR Instrumentsand Reagents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-time PCR Instrumentsand Reagents Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reagent
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Real-time PCR Instrumentsand Reagents Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Prenatal and Postnatal Care
1.3.4 Cancer Screening and Treatment
1.3.5 Organ Transplant
1.3.6 Individual Identification
1.3.7 Agriculture
1.3.8 Customs Quarantine
1.3.9 Food Safety
1.3.10 Forensic
1.3.11 Research and Development
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-time PCR Instrumentsand Reagents Market Perspective (2018-2029)
2.2 Real-time PCR Instrumentsand Reagents Growth Trends by Region
2.2.1 Global Real-time PCR Instrumentsand Reagents Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Real-time PCR Instrumentsand Reagents Historic Market Size by Region (2018-2023)
2.2.3 Real-time PCR Instrumentsand Reagents Forecasted Market Size by Region (2024-2029)
2.3 Real-time PCR Instrumentsand Reagents Market Dynamics
2.3.1 Real-time PCR Instrumentsand Reagents Industry Trends
2.3.2 Real-time PCR Instrumentsand Reagents Market Drivers
2.3.3 Real-time PCR Instrumentsand Reagents Market Challenges
2.3.4 Real-time PCR Instrumentsand Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-time PCR Instrumentsand Reagents Players by Revenue
3.1.1 Global Top Real-time PCR Instrumentsand Reagents Players by Revenue (2018-2023)
3.1.2 Global Real-time PCR Instrumentsand Reagents Revenue Market Share by Players (2018-2023)
3.2 Global Real-time PCR Instrumentsand Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Real-time PCR Instrumentsand Reagents Revenue
3.4 Global Real-time PCR Instrumentsand Reagents Market Concentration Ratio
3.4.1 Global Real-time PCR Instrumentsand Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-time PCR Instrumentsand Reagents Revenue in 2022
3.5 Real-time PCR Instrumentsand Reagents Key Players Head office and Area Served
3.6 Key Players Real-time PCR Instrumentsand Reagents Product Solution and Service
3.7 Date of Enter into Real-time PCR Instrumentsand Reagents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Real-time PCR Instrumentsand Reagents Breakdown Data by Type
4.1 Global Real-time PCR Instrumentsand Reagents Historic Market Size by Type (2018-2023)
4.2 Global Real-time PCR Instrumentsand Reagents Forecasted Market Size by Type (2024-2029)
5 Real-time PCR Instrumentsand Reagents Breakdown Data by Application
5.1 Global Real-time PCR Instrumentsand Reagents Historic Market Size by Application (2018-2023)
5.2 Global Real-time PCR Instrumentsand Reagents Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Real-time PCR Instrumentsand Reagents Market Size (2018-2029)
6.2 North America Real-time PCR Instrumentsand Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Real-time PCR Instrumentsand Reagents Market Size by Country (2018-2023)
6.4 North America Real-time PCR Instrumentsand Reagents Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-time PCR Instrumentsand Reagents Market Size (2018-2029)
7.2 Europe Real-time PCR Instrumentsand Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Real-time PCR Instrumentsand Reagents Market Size by Country (2018-2023)
7.4 Europe Real-time PCR Instrumentsand Reagents Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Real-time PCR Instrumentsand Reagents Market Size (2018-2029)
8.2 Asia-Pacific Real-time PCR Instrumentsand Reagents Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Real-time PCR Instrumentsand Reagents Market Size by Region (2018-2023)
8.4 Asia-Pacific Real-time PCR Instrumentsand Reagents Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Real-time PCR Instrumentsand Reagents Market Size (2018-2029)
9.2 Latin America Real-time PCR Instrumentsand Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Real-time PCR Instrumentsand Reagents Market Size by Country (2018-2023)
9.4 Latin America Real-time PCR Instrumentsand Reagents Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-time PCR Instrumentsand Reagents Market Size (2018-2029)
10.2 Middle East & Africa Real-time PCR Instrumentsand Reagents Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Real-time PCR Instrumentsand Reagents Market Size by Country (2018-2023)
10.4 Middle East & Africa Real-time PCR Instrumentsand Reagents Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Real-time PCR Instrumentsand Reagents Introduction
11.1.4 Thermo Fisher Scientific Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Real-time PCR Instrumentsand Reagents Introduction
11.2.4 Roche Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.2.5 Roche Recent Development
11.3 DaAn Gene
11.3.1 DaAn Gene Company Detail
11.3.2 DaAn Gene Business Overview
11.3.3 DaAn Gene Real-time PCR Instrumentsand Reagents Introduction
11.3.4 DaAn Gene Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.3.5 DaAn Gene Recent Development
11.4 Sansure Biotech
11.4.1 Sansure Biotech Company Detail
11.4.2 Sansure Biotech Business Overview
11.4.3 Sansure Biotech Real-time PCR Instrumentsand Reagents Introduction
11.4.4 Sansure Biotech Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.4.5 Sansure Biotech Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Real-time PCR Instrumentsand Reagents Introduction
11.5.4 QIAGEN Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.5.5 QIAGEN Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Real-time PCR Instrumentsand Reagents Introduction
11.6.4 Bio-Rad Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.6.5 Bio-Rad Recent Development
11.7 Biosynex
11.7.1 Biosynex Company Detail
11.7.2 Biosynex Business Overview
11.7.3 Biosynex Real-time PCR Instrumentsand Reagents Introduction
11.7.4 Biosynex Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.7.5 Biosynex Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Detail
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Real-time PCR Instrumentsand Reagents Introduction
11.8.4 Cepheid Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.8.5 Cepheid Recent Development
11.9 Hangzhou Bloer Technology
11.9.1 Hangzhou Bloer Technology Company Detail
11.9.2 Hangzhou Bloer Technology Business Overview
11.9.3 Hangzhou Bloer Technology Real-time PCR Instrumentsand Reagents Introduction
11.9.4 Hangzhou Bloer Technology Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.9.5 Hangzhou Bloer Technology Recent Development
11.10 Liferiver Bio-Tech
11.10.1 Liferiver Bio-Tech Company Detail
11.10.2 Liferiver Bio-Tech Business Overview
11.10.3 Liferiver Bio-Tech Real-time PCR Instrumentsand Reagents Introduction
11.10.4 Liferiver Bio-Tech Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.10.5 Liferiver Bio-Tech Recent Development
11.11 Xi’an Tianlong Science and Technology
11.11.1 Xi’an Tianlong Science and Technology Company Detail
11.11.2 Xi’an Tianlong Science and Technology Business Overview
11.11.3 Xi’an Tianlong Science and Technology Real-time PCR Instrumentsand Reagents Introduction
11.11.4 Xi’an Tianlong Science and Technology Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.11.5 Xi’an Tianlong Science and Technology Recent Development
11.12 Bioperfectus Technologies
11.12.1 Bioperfectus Technologies Company Detail
11.12.2 Bioperfectus Technologies Business Overview
11.12.3 Bioperfectus Technologies Real-time PCR Instrumentsand Reagents Introduction
11.12.4 Bioperfectus Technologies Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.12.5 Bioperfectus Technologies Recent Development
11.13 BGI Group
11.13.1 BGI Group Company Detail
11.13.2 BGI Group Business Overview
11.13.3 BGI Group Real-time PCR Instrumentsand Reagents Introduction
11.13.4 BGI Group Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.13.5 BGI Group Recent Development
11.14 Agilent Technologies
11.14.1 Agilent Technologies Company Detail
11.14.2 Agilent Technologies Business Overview
11.14.3 Agilent Technologies Real-time PCR Instrumentsand Reagents Introduction
11.14.4 Agilent Technologies Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.14.5 Agilent Technologies Recent Development
11.15 Hybribio
11.15.1 Hybribio Company Detail
11.15.2 Hybribio Business Overview
11.15.3 Hybribio Real-time PCR Instrumentsand Reagents Introduction
11.15.4 Hybribio Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.15.5 Hybribio Recent Development
11.16 Shanghai Biogerm Medical
11.16.1 Shanghai Biogerm Medical Company Detail
11.16.2 Shanghai Biogerm Medical Business Overview
11.16.3 Shanghai Biogerm Medical Real-time PCR Instrumentsand Reagents Introduction
11.16.4 Shanghai Biogerm Medical Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.16.5 Shanghai Biogerm Medical Recent Development
11.17 Shanghai Hongshi Medical Technology
11.17.1 Shanghai Hongshi Medical Technology Company Detail
11.17.2 Shanghai Hongshi Medical Technology Business Overview
11.17.3 Shanghai Hongshi Medical Technology Real-time PCR Instrumentsand Reagents Introduction
11.17.4 Shanghai Hongshi Medical Technology Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.17.5 Shanghai Hongshi Medical Technology Recent Development
11.18 Suzhou Molarray
11.18.1 Suzhou Molarray Company Detail
11.18.2 Suzhou Molarray Business Overview
11.18.3 Suzhou Molarray Real-time PCR Instrumentsand Reagents Introduction
11.18.4 Suzhou Molarray Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.18.5 Suzhou Molarray Recent Development
11.19 Merck
11.19.1 Merck Company Detail
11.19.2 Merck Business Overview
11.19.3 Merck Real-time PCR Instrumentsand Reagents Introduction
11.19.4 Merck Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.19.5 Merck Recent Development
11.20 Analytik Jena
11.20.1 Analytik Jena Company Detail
11.20.2 Analytik Jena Business Overview
11.20.3 Analytik Jena Real-time PCR Instrumentsand Reagents Introduction
11.20.4 Analytik Jena Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.20.5 Analytik Jena Recent Development
11.21 Takara
11.21.1 Takara Company Detail
11.21.2 Takara Business Overview
11.21.3 Takara Real-time PCR Instrumentsand Reagents Introduction
11.21.4 Takara Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.21.5 Takara Recent Development
11.22 Meridian Life Science
11.22.1 Meridian Life Science Company Detail
11.22.2 Meridian Life Science Business Overview
11.22.3 Meridian Life Science Real-time PCR Instrumentsand Reagents Introduction
11.22.4 Meridian Life Science Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.22.5 Meridian Life Science Recent Development
11.23 Promega Corporation
11.23.1 Promega Corporation Company Detail
11.23.2 Promega Corporation Business Overview
11.23.3 Promega Corporation Real-time PCR Instrumentsand Reagents Introduction
11.23.4 Promega Corporation Revenue in Real-time PCR Instrumentsand Reagents Business (2018-2023)
11.23.5 Promega Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details